These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29880031)

  • 1. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels.
    Tiftikci M; Özgür A; He Y; Hur J
    BMC Bioinformatics; 2019 Dec; 20(Suppl 21):707. PubMed ID: 31865904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study.
    Yue QX; Ding RF; Chen WH; Wu LY; Liu K; Ji ZL
    J Med Internet Res; 2024 May; 26():e48572. PubMed ID: 38700923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.
    Guo A; Racz R; Hur J; Lin Y; Xiang Z; Zhao L; Rinder J; Jiang G; Zhu Q; He Y
    J Biomed Semantics; 2016; 7():29. PubMed ID: 27213033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions.
    Yu H; Nysak S; Garg N; Ong E; Ye X; Zhang X; He Y
    BMC Bioinformatics; 2019 May; 20(Suppl 7):199. PubMed ID: 31074377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filtering big data from social media--Building an early warning system for adverse drug reactions.
    Yang M; Kiang M; Shang W
    J Biomed Inform; 2015 Apr; 54():230-40. PubMed ID: 25688695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
    Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
    Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study.
    Li X; Lin X; Ren H; Guo J
    J Med Internet Res; 2020 Jul; 22(7):e20443. PubMed ID: 32706718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information on adverse drug reactions-Proof of principle for a structured database that allows customization of drug information.
    Kusch MKP; Zien A; Hachenberg C; Haefeli WE; Seidling HM
    Int J Med Inform; 2020 Jan; 133():103970. PubMed ID: 31704490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms.
    Cai MC; Xu Q; Pan YJ; Pan W; Ji N; Li YB; Jin HJ; Liu K; Ji ZL
    Nucleic Acids Res; 2015 Jan; 43(Database issue):D907-13. PubMed ID: 25361966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the common genetic networks of ADR (adverse drug reaction) clusters and developing an ADR classification model.
    Hwang Y; Oh M; Jang G; Lee T; Park C; Ahn J; Yoon Y
    Mol Biosyst; 2017 Aug; 13(9):1788-1796. PubMed ID: 28702565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mining FDA drug labels using an unsupervised learning technique--topic modeling.
    Bisgin H; Liu Z; Fang H; Xu X; Tong W
    BMC Bioinformatics; 2011 Oct; 12 Suppl 10(Suppl 10):S11. PubMed ID: 22166012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constructing a Gene-Drug-Adverse Reactions Network and Inferring Potential Gene-Adverse Reactions Associations Using a Text Mining Approach.
    Sui M; Cui L
    Stud Health Technol Inform; 2017; 245():531-535. PubMed ID: 29295151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontology-based literature mining of E. coli vaccine-associated gene interaction networks.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2017 Mar; 8(1):12. PubMed ID: 28288685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects.
    Wang Y; Chen X; Liu L; Chen Y; Ma H; Yang R; Liu X
    Mol Biosyst; 2015 Jul; 11(7):2060-7. PubMed ID: 25992869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.